Anzeige
Mehr »
Samstag, 10.01.2026 - Börsentäglich über 12.000 News
Fundamental stark, Kurs zu niedrig - Chance beim Krebs-Impfstoff-Pionier!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Investing.com

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
02:18Cathie Wood's ARK ETF Buys Intellia, Personalised Stock; Sells Illumina
FrBARK receives $0.90 per share buyout offer from CEO-led investor group
FrWynn Resorts names Craig Fullalove as new CFO as Cameron-Doe plans retirement
FrBleichroeder Acquisition Corp. II raises $287.5 million in IPO
FrLendingTree promotes Ian Smith to COO, Laura Nelson to head insurance
FrWebuy Global receives Nasdaq non-compliance notice over equity minimum
FrVasta to delist from Nasdaq following Cogna's acquisition
FrSaratoga Casino Holdings invests $1 million in High Roller Technologies
Fr3E Network Technology completes $500,000 convertible note offering
FrCoca-Cola Consolidated declares $0.25 quarterly dividend
FrK Wave Media receives Nasdaq minimum bid price deficiency notice
FrBank of America to redeem $3 billion in senior notes ahead of maturity
FrAlumis raises $345.1 million in upsized public offering
FrAutozi regains bid price compliance but faces Nasdaq delisting hearing
FrJack in the Box repays $105 million in secured notes
FrAon declares quarterly cash dividend of $0.745 per share
FrBank of the James co-founder Todd Scruggs retires after 25-year tenure
FrVCI Global's AI GPU lounge reaches operational readiness in Malaysia
FrCG Oncology stock price target raised to $93 from $89 at Morgan Stanley
FrWalmart stock rolls back prices on wellness items, launches Better Care Services
FrChina SXT Pharmaceuticals to raise $10 million in share offering
FrWilliam Blair reiterates Market Perform rating on Neogen stock after Q2 beat
FrMeta stock price target maintained at $1,117 by Rosenblatt on nuclear power deals
FrRhythm Pharmaceuticals stock price target raised to $130 from $120 at TD Cowen
FrEason Technology receives NYSE notification for late filing